Related Experiment Video
Updated: Jul 4, 2026
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
A retrovirus-based system to stably silence GDF-8 expression and enhance myogenic differentiation in human
Zhuo Yang1, Jingwu Zhang, Haolong Cong
1Molecular Virology Research Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing, PR China.
Background:
Myostatin, also called GDF-8, a secreted growth and differentiating factor that belongs to the transforming growth factor-beta superfamily, is a known negative regulator of myogenesis in vivo. Overexpression of GDF-8 contributes to the lack of differentiation in human rhabdomyosarcoma (RMS) cells. We investigated whether a retrovirus-based RNA interference (RNAi) system against GDF-8 expression in human RMS cells would enhance myogenic differentiation.
Methods:
A retrovirus-based RNAi system was developed that utilized the U6-RNA polymerase III promoter to drive efficient expression and deliver the GDF8-specific short hairpin RNAs (shRNAs) in human RMS cell A204. In this system, the retrovirus vector was integrated into the host cell genome and allowed stable expression of shRNAs. GDF-8 expression was determined by real-time polymerase chain reaction and western blotting analysis. An 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was performed to determine the cell proliferation. Myogenic differentiation markers were monitored by western blotting analysis. Cell cycle and apoptosis was determined by propidium iodide staining and analysed in a flow cytometer.
Results:
In the siGDF8 A204 cell pools, the levels of both GDF-8 mRNA and protein were dramatically reduced by this RNAi system. In differentiation conditions, inhibition of myostatin synthesis led to enhanced cell cycle withdrawal, consequently stimulated myogenic differentiation and increased the rate of tumor cell apoptosis.
Conclusions:
The results demonstrate that deactivation of myostatin by using retrovirus-based RNAi thus may be useful for therapy in rhabdomyosarcomas.
Insights
This study developed a retrovirus-based RNA interference system to inhibit myostatin (GDF-8) in human rhabdomyosarcoma cells. Inhibition of myostatin enhanced myogenic differentiation and tumor cell apoptosis, suggesting potential therapeutic applications.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Myostatin (GDF-8) is a negative regulator of myogenesis.
- Overexpression of GDF-8 inhibits differentiation in human rhabdomyosarcoma (RMS) cells.
Purpose of the Study:
- To investigate if a retrovirus-based RNA interference (RNAi) system targeting GDF-8 can enhance myogenic differentiation in human RMS cells.
Main Methods:
- Developed a retrovirus-based RNAi system using U6-RNA polymerase III promoter for GDF8-specific short hairpin RNAs (shRNAs).
- Validated GDF-8 knockdown via real-time PCR and Western blotting.
- Assessed cell proliferation, myogenic differentiation markers, cell cycle, and apoptosis.
Main Results:
- Achieved significant reduction in GDF-8 mRNA and protein levels in A204 RMS cells.
- Inhibition of myostatin stimulated myogenic differentiation by promoting cell cycle withdrawal.
- Observed an increased rate of tumor cell apoptosis following myostatin inhibition.
Conclusions:
- Retrovirus-mediated RNAi targeting myostatin effectively inhibits its expression in RMS cells.
- Deactivation of myostatin shows promise as a therapeutic strategy for rhabdomyosarcomas.
